E-LIB Suche - Ergebnisse für: Antela, A

1

Risk of cardiovascular disease in patients with HIV infecti..:

Estrada, V. ; Domingo, P. ; Suarez-Lozano, I....
Revista Clínica Española (English Edition). 220 (2020) 3 - p. 149-154 , 2020

Link: https://doi.org/10.1016/..

2

Primary resistance to integrase strand transfer inhibitors ..:

Casadellà, M ; Santos, J R ; Noguera-Julian, M...
Journal of Antimicrobial Chemotherapy. 75 (2020) 12 - p. 3517-3524 , 2020

Link: https://doi.org/10.1093/..

3

The role of tenofovir alafenamide in future HIV management:

Antela, A ; Aguiar, C ; Compston, J...
HIV Medicine. 17 (2016) S2 - p. 4-16 , 2016

Link: https://doi.org/10.1111/..

4

Simplification to dual therapy (atazanavir/ritonavir + lami..:

Perez-Molina, J. A. ; Rubio, R. ; Rivero, A....
Journal of Antimicrobial Chemotherapy. 72 (2016) 1 - p. 246-253 , 2016

Link: https://doi.org/10.1093/..

5

Interpreting the reasons for the choice and changing of two..:

Jarrin, I ; Hernández-Novoa, B ; Alejos, B...
HIV Medicine. 15 (2014) 9 - p. 547-556 , 2014

Link: https://doi.org/10.1111/..

6

Long‐term efficacy and safety of atazanavir/ritonavir treat..:

Teófilo, E ; Knechten, H ; Antela, A...
Journal of the International AIDS Society. 15 (2012) S4 - p. 1-1 , 2012

Link: https://doi.org/10.7448/..

7

Tuberculous hepatic abscess appearing after liver transplan..:

Rodríguez‐Framil, M. ; Antela, A. ; Prieto, A....
Transplant Infectious Disease. 13 (2011) 5 - p. 515-519 , 2011

Link: https://doi.org/10.1111/..

8

Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg ..:

Casado, JL ; Domingo, P ; Rubio, R...
Journal of the International AIDS Society. 13 (2010) - p. P49-P49 , 2010

Link: https://doi.org/10.1186/..

9

Switching to nevirapine (NVP) significantly increases high-..:

Rodriguez, JM ; Delgado, M ; Viciana, P...
Journal of the International AIDS Society. 13 (2010) - p. P79-P79 , 2010

Link: https://doi.org/10.1186/..

10

Effect of food on the antiviral activity of didanosine ente..:

Hernández‐Novoa, B ; Antela, A ; Gutiérrez, C...
HIV Medicine. 9 (2008) 4 - p. 187-191 , 2008

Link: https://doi.org/10.1111/..

11

Positive predictive factors in HIV-1 patients treated with ..:

Ribera, E ; Antela, A ; Henarejos, JA Garcia...
Journal of the International AIDS Society. 11 (2008) Suppl 1 - p. P44 , 2008

Link: https://doi.org/10.1186/..

12

Viral kinetics and early prediction of nonresponse to peg‐I..:

Moreno, A. ; Bárcena, R. ; García‐Garzón, S....
Journal of Viral Hepatitis. 13 (2006) 7 - p. 466-473 , 2006

Link: https://doi.org/10.1111/..

13

206 Safe use of peg-ifn and ribavirin in hcv-cirrhotic pati..:

Bárcena, R. ; Moreno, A. ; Foruny, J.R....
Journal of Hepatology. 44 (2006) - p. S84-S85 , 2006

Link: https://doi.org/10.1016/..

14

Once-daily antiretroviral therapy: Spanish Consensus Statem..:

Pulido, F. ; Ribera, E. ; Moreno, S....
Journal of Antimicrobial Chemotherapy. 56 (2005) 5 - p. 808-818 , 2005

Link: https://doi.org/10.1093/..

15

Influence of Liver Fibrosis on Highly Active Antiretroviral..:

Aranzabal, L. ; Casado, J. L. ; Moya, J....
Clinical Infectious Diseases. 40 (2005) 4 - p. 588-593 , 2005

Link: https://doi.org/10.1086/..